{"id":"current-regimen","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Increased liver enzymes"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Remdesivir works by targeting the viral RNA-dependent RNA polymerase, preventing the virus from replicating. This mechanism of action is effective against a broad range of RNA viruses, including SARS-CoV-2.","oneSentence":"Repurposed to treat COVID-19 by inhibiting viral replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:29.011Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of COVID-19"},{"name":"Treatment of Ebola virus disease"}]},"trialDetails":[{"nctId":"NCT06819176","phase":"PHASE1","title":"Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-20","conditions":"Human Immunodeficiency Virus","enrollment":50},{"nctId":"NCT07369856","phase":"NA","title":"Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Cardiology Research UBC","startDate":"2025-11-04","conditions":"Heart Failure, Diuretics","enrollment":300},{"nctId":"NCT07371650","phase":"PHASE2","title":"This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza","status":"ACTIVE_NOT_RECRUITING","sponsor":"Traws Pharma, Inc.","startDate":"2025-12-15","conditions":"Influenza","enrollment":105},{"nctId":"NCT07496528","phase":"NA","title":"Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-04-01","conditions":"Colorectal Neoplasms, Ileus Postoperative, Postoperative Complication","enrollment":240},{"nctId":"NCT07285460","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-12-18","conditions":"Hemophilia","enrollment":85},{"nctId":"NCT00931463","phase":"PHASE4","title":"A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2009-09","conditions":"HIV Infections","enrollment":558},{"nctId":"NCT07493538","phase":"PHASE2","title":"MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases","status":"NOT_YET_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2026-08","conditions":"AML, MDS, Acute Leukemia","enrollment":132},{"nctId":"NCT01500551","phase":"PHASE2, PHASE3","title":"Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-03-18","conditions":"Juvenile Idiopathic Arthritis","enrollment":302},{"nctId":"NCT05034432","phase":"PHASE4","title":"The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2022-05-27","conditions":"Arrythmia, Cardiomyopathies","enrollment":100},{"nctId":"NCT07426055","phase":"PHASE2, PHASE3","title":"PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","startDate":"2026-03-19","conditions":"Prostate Cancer (Adenocarcinoma), Prostate Brachytherapy, Stereotactic Body Radiation Therapy (SBRT)","enrollment":1200},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT05238155","phase":"","title":"Evaluation of the Impact of Reduced Immunosuppression","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2021-10-19","conditions":"Graft Vs Host Disease","enrollment":100},{"nctId":"NCT06568549","phase":"PHASE4","title":"Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-06-13","conditions":"Kidney Transplantation, Mycophenolate Mofetil","enrollment":350},{"nctId":"NCT00068003","phase":"","title":"Harvesting Cells for Experimental Cancer Treatments","status":"ENROLLING_BY_INVITATION","sponsor":"National Cancer Institute (NCI)","startDate":"2003-09-08","conditions":"Melanoma, Gastrointestinal Cancer, Metastatic Cancer","enrollment":7000},{"nctId":"NCT05480228","phase":"PHASE2","title":"EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA","status":"COMPLETED","sponsor":"James P. Rathmell, MD","startDate":"2022-09-21","conditions":"Painful Diabetic Neuropathy","enrollment":127},{"nctId":"NCT06998524","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-06-27","conditions":"Von Willebrand Disease, Type 3","enrollment":75},{"nctId":"NCT06500273","phase":"PHASE2","title":"Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL","status":"RECRUITING","sponsor":"Allogene Therapeutics","startDate":"2024-06-18","conditions":"Large B-cell Lymphoma","enrollment":250},{"nctId":"NCT07480707","phase":"NA","title":"Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?","status":"NOT_YET_RECRUITING","sponsor":"Fatty Acid Research Institute","startDate":"2026-05-01","conditions":"Omega-3 Fatty Acids","enrollment":48},{"nctId":"NCT06883240","phase":"","title":"An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-04-29","conditions":"Von Willebrand Disease, Type 3","enrollment":40},{"nctId":"NCT03486873","phase":"PHASE3","title":"Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-08-21","conditions":"Solid Tumors, Hematologic Malignancies","enrollment":3500},{"nctId":"NCT07463235","phase":"PHASE3","title":"Safety and Potency of a High Cabergoline Dosage in Microprolactinomas","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-03-04","conditions":"Prolactinoma, Prolactin Excess","enrollment":70},{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT01804686","phase":"PHASE3","title":"A Long-term Extension Study of PCI-32765 (Ibrutinib)","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2013-09-09","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma","enrollment":700},{"nctId":"NCT07466277","phase":"NA","title":"Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12-09","conditions":"Social Anxiety Disorder (SAD)","enrollment":100},{"nctId":"NCT01962636","phase":"NA","title":"Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-12","conditions":"Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia","enrollment":200},{"nctId":"NCT07352592","phase":"NA","title":"Process-Based Approach Case Series For Anxiety Problems","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-05-01","conditions":"Anxiety","enrollment":10},{"nctId":"NCT07461961","phase":"PHASE2","title":"CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-07-01","conditions":"Cardiogenic Shock, Heart Failure, Inflammation","enrollment":30},{"nctId":"NCT07461441","phase":"PHASE3","title":"Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy","status":"RECRUITING","sponsor":"Yeungnam University College of Medicine","startDate":"2026-03-01","conditions":"Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration","enrollment":50},{"nctId":"NCT07263867","phase":"NA","title":"Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy","status":"NOT_YET_RECRUITING","sponsor":"LanZhou University","startDate":"2026-03-28","conditions":"Colonoscopy, Bowel Preparation, Quality of Healthcare","enrollment":300},{"nctId":"NCT06784297","phase":"","title":"INTERMEDIATE-SIZE PATIENT POPULATIONS EXPANDED ACCESS TO TREATMENT FOR SARCOPENIC OBESITY","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Immunis, Inc.","startDate":"","conditions":"Sarcopenia, Obesity and Obesity-related Medical Conditions","enrollment":""},{"nctId":"NCT02088658","phase":"NA","title":"Technology Intensified Diabetes Education Study in African Americans","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2013-05","conditions":"Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent","enrollment":200},{"nctId":"NCT06860802","phase":"PHASE1","title":"Precision Antibiotic Dosing for Appendectomy","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-02-28","conditions":"Appendicitis (Diagnosis)","enrollment":46},{"nctId":"NCT04582383","phase":"PHASE4","title":"Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-30","conditions":"Acne","enrollment":350},{"nctId":"NCT02354014","phase":"PHASE2","title":"Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2016-05-03","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":60},{"nctId":"NCT06713200","phase":"NA","title":"Effectiveness of Percutaneous Electrolysis in Subacute and Early Chronic Medial Gastrocnemius Muscle Injuries","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2024-11-26","conditions":"Muscle Injury, Fibrosis","enrollment":75},{"nctId":"NCT03849651","phase":"PHASE2","title":"TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-01-31","conditions":"Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)","enrollment":69},{"nctId":"NCT05091424","phase":"PHASE1","title":"A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-03-07","conditions":"Chronic Lymphocytic Leukemia","enrollment":137},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT07421141","phase":"PHASE2","title":"De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Radiological Centre of the Ministry of Health of Russia","startDate":"2023-09-01","conditions":"Breast Cancer, HER2-positive Breast Cancer, Early Breast Cancer","enrollment":186},{"nctId":"NCT07436494","phase":"","title":"Coronavirus Anxiety in Patients Using Biologic vs Conventional DMARDs","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2020-10-15","conditions":"COVID-19, Anxiety, Rheumatic Diseases","enrollment":200},{"nctId":"NCT07432178","phase":"PHASE3","title":"CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-02-23","conditions":"Breast Cancer","enrollment":2288},{"nctId":"NCT07431736","phase":"NA","title":"Laser Therapy for Dentin Hypersensitivity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hacettepe University","startDate":"2025-11-11","conditions":"Dentin Hypersensitivity","enrollment":25},{"nctId":"NCT05316584","phase":"NA","title":"A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2022-09-06","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis","enrollment":123},{"nctId":"NCT03088540","phase":"PHASE3","title":"Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2017-05-29","conditions":"Carcinoma，Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma","enrollment":712},{"nctId":"NCT05334706","phase":"PHASE4","title":"A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)","status":"RECRUITING","sponsor":"Miquel Angel Pavon Ribas","startDate":"2022-09-13","conditions":"Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV","enrollment":69},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT02616666","phase":"PHASE4","title":"A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2016-08-25","conditions":"Type 2 Diabetes Mellitus","enrollment":632},{"nctId":"NCT06675955","phase":"PHASE3","title":"An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2024-12-13","conditions":"Multiple Sclerosis","enrollment":500},{"nctId":"NCT06290687","phase":"PHASE2","title":"Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-02-18","conditions":"Malignant Neoplasm of Bladder, Muscle Invasive Bladder Carcinoma","enrollment":40},{"nctId":"NCT07413146","phase":"NA","title":"Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-02-24","conditions":"Minimal Residual Disease, Immunoscore, Neoadjuvant Chemotherapy","enrollment":100},{"nctId":"NCT05836987","phase":"PHASE3","title":"The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-07-13","conditions":"Atrial Fibrillation","enrollment":5350},{"nctId":"NCT06491030","phase":"PHASE4","title":"Post-Operative Thoracolumosacral Orthosis for PJK","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2024-12-02","conditions":"Proximal Junctional Kyphosis, Adult Spinal Deformity Surgery, Thoracolumbosacral Orthosis","enrollment":84},{"nctId":"NCT06003309","phase":"NA","title":"Frequency and E-field Enhancement of ITBS for Depression (FREED)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2023-08-31","conditions":"Major Depressive Disorder","enrollment":75},{"nctId":"NCT07407530","phase":"NA","title":"Comparison of 'Sip Til Send' Regimens Prior to Elective Caesarean Delivery Using Bedside Gastric Ultrasound","status":"RECRUITING","sponsor":"The Rotunda Hospital","startDate":"2025-08-01","conditions":"Gastric Emptying, Caesarean Delivery, Pregnancy","enrollment":190},{"nctId":"NCT03681028","phase":"PHASE1","title":"Feasibility of Individualized Therapy for Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Jennifer Clarke","startDate":"2018-12-19","conditions":"Recurrent Glioblastoma","enrollment":30},{"nctId":"NCT06767306","phase":"PHASE2","title":"Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma","status":"RECRUITING","sponsor":"Melanoma Institute Australia","startDate":"2025-03-06","conditions":"Melanoma Metastatic","enrollment":129},{"nctId":"NCT07404436","phase":"PHASE4","title":"Rivaroxaban in Idiopathic Membranous Nephropathy","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-01-05","conditions":"Idiopathic Membranous Nephropathy","enrollment":134},{"nctId":"NCT04661137","phase":"PHASE2","title":"A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma","status":"SUSPENDED","sponsor":"Hackensack Meridian Health","startDate":"2021-03-16","conditions":"Multiple Myeloma","enrollment":96},{"nctId":"NCT07399145","phase":"NA","title":"Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP)","status":"COMPLETED","sponsor":"Balnear and Rehabilitation Sanatorium Techirghiol","startDate":"2025-04-01","conditions":"Low Back Pain","enrollment":84},{"nctId":"NCT04478279","phase":"PHASE1, PHASE2","title":"A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sapience Therapeutics","startDate":"2020-07-01","conditions":"Glioblastoma, Melanoma Stage IV, Breast Cancer","enrollment":125},{"nctId":"NCT03947684","phase":"","title":"Exploring the Modulatory Role of Sex Hormones Along the Neuromechanical Axis in Females","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-04-12","conditions":"Role of Sex Hormones Along the Neuromechanical Axis","enrollment":102},{"nctId":"NCT03981835","phase":"","title":"Management of Antiplatelet Regimen During Surgical Procedures","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2019-08-01","conditions":"Cardiac Surgery, Surgery, Percutaneous Coronary Intervention","enrollment":147},{"nctId":"NCT07389473","phase":"","title":"Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device","status":"RECRUITING","sponsor":"Gaize","startDate":"2024-04-17","conditions":"ADHD, Depression Disorders, Mood Disorders","enrollment":50},{"nctId":"NCT07385989","phase":"PHASE2","title":"Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"WEI XU","startDate":"2026-01-25","conditions":"Extranodal NK/T-cell Lymphoma","enrollment":40},{"nctId":"NCT06419517","phase":"NA","title":"Pelvic Muscle Training and Electrostimulation to Treat Weak Pelvic Floor","status":"COMPLETED","sponsor":"Azienda Unita Sanitaria Locale di Piacenza","startDate":"2024-05-17","conditions":"Pelvic Floor Muscle Weakness, Incontinence Stress, Electricity; Effects","enrollment":50},{"nctId":"NCT07381764","phase":"PHASE2","title":"ROMANCE: \"Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer\"","status":"NOT_YET_RECRUITING","sponsor":"Gruppo Oncologico Italia Meridionale","startDate":"2026-03-30","conditions":"Metastatic Colorectal Cancer (CRC)","enrollment":150},{"nctId":"NCT06193486","phase":"PHASE1","title":"Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-10-26","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":30},{"nctId":"NCT04621929","phase":"PHASE3","title":"Phentermine/Topiramate for Uric Acid Stones","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":"Obesity, Uric Acid Stones, Type 2 Diabetes Mellitus in Obese","enrollment":19},{"nctId":"NCT07378683","phase":"NA","title":"A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery","status":"RECRUITING","sponsor":"Ming Yang","startDate":"2025-06-01","conditions":"Surgical Site Infection (SSI), Central Nervous System Tumor","enrollment":500},{"nctId":"NCT03856632","phase":"PHASE4","title":"Liraglutide Effect in Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2019-03-18","conditions":"Atrial Fibrillation","enrollment":60},{"nctId":"NCT03952299","phase":"PHASE3","title":"Oxybutynin for Post-surgical Bladder Pain and Urgency","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2021-09-01","conditions":"Overactive Bladder Syndrome, Neuropathic Bladder","enrollment":100},{"nctId":"NCT07375563","phase":"PHASE3","title":"Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2025-11-19","conditions":"Neuroblastoma (NB), Ganglioneuroblastoma","enrollment":5},{"nctId":"NCT06972368","phase":"NA","title":"Home-Based tDCS for Depression in BPD","status":"RECRUITING","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2026-01-01","conditions":"Major Depressive Disorder (MDD), Borderline Personality Disorders","enrollment":60},{"nctId":"NCT07228468","phase":"NA","title":"Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-11-18","conditions":"Major Depressive Disorder (MDD)","enrollment":438},{"nctId":"NCT07366801","phase":"PHASE2, PHASE3","title":"Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2025-09-03","conditions":"Acute Myeloid Leukemia, Relapsed, Acute Lymphoblastic Leukemia, High Risk, Acute Myeloid Leukemia, High Risk","enrollment":64},{"nctId":"NCT07025226","phase":"EARLY_PHASE1","title":"Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-12","conditions":"Glioma","enrollment":10},{"nctId":"NCT06909240","phase":"NA","title":"Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)","status":"RECRUITING","sponsor":"Hvidovre University Hospital","startDate":"2025-11-15","conditions":"Deep Vein Thrombosis (DVT)","enrollment":152},{"nctId":"NCT06692673","phase":"PHASE1, PHASE2","title":"Linaclotide for Colonoscopy Bowel Prep","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-12-01","conditions":"Patients Scheduled for Colonoscopy","enrollment":10},{"nctId":"NCT05964140","phase":"PHASE3","title":"The MANTRA Trial (MANdibular TRauma and Antibiotic Use)","status":"RECRUITING","sponsor":"East Lancashire Hospitals NHS Trust","startDate":"2024-12-06","conditions":"Mandible Fracture, Post-operative Antibiotics","enrollment":2841},{"nctId":"NCT05287568","phase":"PHASE1","title":"CC-486 and Venetoclax for Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-12-19","conditions":"AML","enrollment":35},{"nctId":"NCT01652092","phase":"NA","title":"Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-09-04","conditions":"SCID, Omenn's Syndrome, Reticular Dysgenesis","enrollment":57},{"nctId":"NCT07076069","phase":"PHASE4","title":"The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2025-07-21","conditions":"Rotator Cuff Repairs, Pain Management","enrollment":130},{"nctId":"NCT07335406","phase":"","title":"Registry for the Management of Helicobacter Pylori Infection in Shandong Province","status":"NOT_YET_RECRUITING","sponsor":"Yueyue Li","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":10000},{"nctId":"NCT06928922","phase":"EARLY_PHASE1","title":"Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-02-24","conditions":"Advanced Lung Cancer, Lung Metastasis","enrollment":83},{"nctId":"NCT04786067","phase":"PHASE4","title":"Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2021-07-28","conditions":"Kidney Transplant Immunosuppression","enrollment":25},{"nctId":"NCT05354869","phase":"NA","title":"Transvaginal Electrical Stimulation for Myofascial Pelvic Pain","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-10-31","conditions":"Myofascial Pelvic Pain","enrollment":60},{"nctId":"NCT06910124","phase":"PHASE2","title":"Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse","status":"RECRUITING","sponsor":"Dickran Kazandjian, MD","startDate":"2025-12-02","conditions":"Multiple Myeloma","enrollment":32},{"nctId":"NCT03754114","phase":"NA","title":"Brain Oxygen Optimization in Severe TBI, Phase 3","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2019-08-28","conditions":"Brain Injuries, Traumatic","enrollment":1094},{"nctId":"NCT07320989","phase":"NA","title":"Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2025-12-21","conditions":"Colon Cancer Screening","enrollment":100},{"nctId":"NCT07318727","phase":"NA","title":"Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-01-10","conditions":"Endometrium Cancer","enrollment":81},{"nctId":"NCT05614102","phase":"PHASE1","title":"A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2022-11-04","conditions":"Advanced Solid Tumors","enrollment":284},{"nctId":"NCT07316049","phase":"NA","title":"Construction and Evaluation of an Intelligent Decision System for Reperfusion Therapy in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12-15","conditions":"Acute Ischemic Stroke","enrollment":3000},{"nctId":"NCT05675319","phase":"PHASE3","title":"Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy","status":"TERMINATED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2023-03-03","conditions":"Multiple Myeloma","enrollment":28},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":618},{"nctId":"NCT03760731","phase":"NA","title":"Thriving in the Midst of Moral Pain: The Acceptability and Feasibility of Acceptance and Commitment Therapy for Moral Injury (ACT-MI) Among Warzone Veterans","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-04-01","conditions":"Moral Injury","enrollment":74},{"nctId":"NCT07307443","phase":"PHASE2","title":"A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Zhijie Wang","startDate":"2026-02-01","conditions":"SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer","enrollment":28},{"nctId":"NCT07288502","phase":"","title":"Adherence to Secondary Prevention Drugs and Influencing Factors After Acute Coronary Syndrome in Patients at a Tertiary Center in Nepal","status":"COMPLETED","sponsor":"Institute of medicine, Maharagjung medical campus","startDate":"2024-08-01","conditions":"Acute Coronary Syndromes (ACS), Adherence","enrollment":109},{"nctId":"NCT04740567","phase":"NA","title":"Early Cognitive Intervention in Delirium","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-02-09","conditions":"Delirium, Cognitive Decline, Dementia","enrollment":283},{"nctId":"NCT04573673","phase":"NA","title":"Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2021-12-01","conditions":"Multiple Sclerosis, Lower Urinary Tract Symptoms","enrollment":68},{"nctId":"NCT05259501","phase":"NA","title":"Remote Methadone Ingestion Surveillance Trial (RMIST)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-01-15","conditions":"Opioid Use Disorder","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":361,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Current HIV treatment regimen"],"phase":"marketed","status":"active","brandName":"Current Regimen","genericName":"Current Regimen","companyName":"University of Chicago","companyId":"university-of-chicago","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Repurposed to treat COVID-19 by inhibiting viral replication. Used for Treatment of COVID-19, Treatment of Ebola virus disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}